Eleff S, Kennaway N G, Buist N R, Darley-Usmar V M, Capaldi R A, Bank W J, Chance B
Proc Natl Acad Sci U S A. 1984 Jun;81(11):3529-33. doi: 10.1073/pnas.81.11.3529.
The bioenergetic capacity of skeletal muscle in a 17-year-old patient with a severe defect in complex III of the electron transport chain has been examined by 31P NMR measurements of the molar ratio of phosphocreatine to inorganic phosphate (PCr/Pi). Resting ratios were 1.3-2.5, which can be compared with roughly 8.6 for a young, normal female control at rest. Quantitative evaluation of the activity of oxidative metabolism was afforded by the rate of recovery of PCr/Pi from exercise and was found to be 2.5% of normal. After administration of menadione and ascorbate, we found a 21-fold increase of the recovery rate relative to the pretherapy value, to within 56% of the recovery rate of the young female control. Thus, NMR examinations of skeletal muscle at rest and in recovery from activity document marked improvement to specific drug therapy in the electron transport capabilities and the ATP synthesis rate of a patient with a deficiency in a cytochrome b-containing complex III. Improvements in functional ability, although not as dramatic as biochemical changes, are also apparent.
通过对一名17岁电子传递链复合体III严重缺陷患者的骨骼肌进行31P核磁共振测量磷酸肌酸与无机磷酸的摩尔比(PCr/Pi),研究了其生物能量学能力。静息比值为1.3 - 2.5,与之相比,年轻正常女性静息时该比值约为8.6。氧化代谢活性的定量评估通过运动后PCr/Pi的恢复率进行,结果发现该患者的恢复率仅为正常的2.5%。给予甲萘醌和抗坏血酸后,我们发现恢复率相对于治疗前的值增加了21倍,达到年轻女性对照恢复率的56%以内。因此,对静息及活动恢复过程中骨骼肌的核磁共振检查证明,对于一名含细胞色素b的复合体III缺乏患者,特定药物治疗在电子传递能力和ATP合成速率方面有显著改善。功能能力的改善虽然不如生化变化那么显著,但也很明显。